glp-1 week 1 Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 Medications Infographic | Medidex

Coverage criteria may include: BMI requirements for obesity or overweight with comorbidities

If you notice decreased urine output or swelling, seek medical attention immediately

Cai CX, Hribar M, Nishimura A

Semaglutide , on the other hand, stands out as a more advanced and widely researched option

Based on the strength of the clinical data, we expect Wegovy to be added to formularies with utilization management restrictions for prior authorization to prevent off-label use, shorter initial approval periods (e.g., six months approved initially) to ensure efficacy, and quantity limits to reduce stockpiling and waste